Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:S7-S15
doi: 10.1161/CIRCULATIONAHA.107.783126
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ElBardissi, A. W.
Right arrow Articles by Schaff, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ElBardissi, A. W.
Right arrow Articles by Schaff, H. V.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Surgery
Related Collections
Right arrow CV surgery: other
Right arrow Epidemiology

(Circulation. 2008;118:S7-S15.)
© 2008 American Heart Association, Inc.


Original Articles

Survival After Resection of Primary Cardiac Tumors

A 48-Year Experience

Andrew W. ElBardissi, MD, MPH; Joseph A. Dearani, MD; Richard C. Daly, MD; Charles J. Mullany, MD; Thomas A. Orszulak, MD; Francisco J. Puga, MD; Hartzell V. Schaff, MD

From the Brigham and Women’s Hospital (A.W.E.), and Harvard Medical School, Boston, Mass; and the Mayo Clinic (J.A.D., R.C.D., C.J.M., T.A.O., F.J.P., H.V.S.), Rochester, Minn.

Correspondence to Andrew W. ElBardissi, MD, MPH, Department of Surgery, Brigham and Women’s Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115. E-mail aelbardissi{at}partners.org

Background— Primary cardiac tumors are rare but have the potential to cause significant morbidity if not treated in an appropriate and timely manner. To date, however, there have been no studies examining survival characteristics of patients who undergo surgical resection.

Methods and Results— From 1957 to 2006, 323 consecutive patients underwent surgical resection of primary cardiac tumors; 163 (50%) with myxomas, 83 (26%) with papillary fibroelastomas, 18 (6%) with fibromas, 12 (4%) with lipomas, 28 (9%) with other benign primary cardiac tumors, and 19 (6%) with primary malignant tumors. Operative (30 day) mortality was 2% (n=6). Univariate analysis indicated that patients who underwent resection of fibromas and myxomas had superior survival characteristics in comparison to the remainder of tumor variants; these results were consistent after adjusting for age at surgery, year of surgery, and cardiovascular risk factors. Based on actuarial characteristics of the 2002 U.S. population, patients who underwent myxoma resection had survival characteristics that were not significantly different from that of an age and gender matched population (SMR 1.11, P=0.57) whereas those who underwent resection of fibromas (SMR 11.17, P=0.002), papillary fibroelastomas (SMR 3.17, P=0.0003), lipomas (SMR 5.0, P=0.0003), other benign tumors (SMR 4.63, P=0.003), and malignant tumors (SMR 101, P<0.0001) had significantly poorer survival characteristics. Furthermore, malignant tumors in younger patients were highly fatal (HR 0.899, P<0.0001). Although the most significant predictor of mortality was tumor histology, survival was also influenced the by the duration of CPB and NYHA III/IV; the impact of these risk factors varied with time. The cumulative incidence of myxoma recurrence was 13% and occurred in a younger population (42 versus 57 years, P=0.003) with the risk of recurrence decreased after 4 years.

Conclusions— Surgical resection of primary cardiac tumors is associated with excellent long-term survival; patients with cardiac myxomas have survival characteristics that are not significantly different from that of a general population. Predictors of mortality are primarily related to tumor histology but also include clinical characteristics such as symptomatology and duration of CPB.


Key Words: cardiac tumor • myxoma • lipoma • fibroma • malignant sarcoma • survival • surgical resection




This article has been cited by other articles:


Home page
BMJHome page
C. Kiblbock, W. Schutzenberger, J. Kammler, J. Demmer, and F. Leisch
Transient loss of consciousness and a heart murmur
BMJ, September 2, 2009; 339(sep02_2): b3323 - b3323.
[Full Text]


Home page
BMJ Case ReportsHome page
J. F. M. Marchini, A. J. Rodrigues, and A. Schmidt
A ventricular thrombus mimicking a tumour
BMJ Case Reports, September 1, 2009; 2009(aug31_1): bcr0620091944 - bcr0620091944.
[Abstract] [Full Text]


Home page
ESC Textbook of Cardiovascular MedicineHome page
G. Thiene, M. Valente, M. Lombardi, and C. Basso
CHAPTER 20 Tumours of the Heart
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]